Cubist Systematic Strategies’s Esperion Therapeutics ESPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-273,292
Closed -$732K 3275
2024
Q1
$732K Buy
273,292
+88,321
+48% +$215K ﹤0.01% 2381
2023
Q4
$553K Buy
184,971
+72,169
+64% +$93.6K ﹤0.01% 2468
2023
Q3
$111K Buy
+112,802
New +$163K ﹤0.01% 2921
2023
Q2
Sell
-42,304
Closed -$67.3K 3730
2023
Q1
$67.3K Sell
42,304
-118,834
-74% -$613K ﹤0.01% 3516
2022
Q4
$1M Sell
161,138
-199,914
-55% -$1.43M 0.01% 2441
2022
Q3
$2.42M Buy
361,052
+105,215
+41% +$723K 0.01% 1804
2022
Q2
$1.63M Buy
255,837
+193,725
+312% +$1.1M 0.01% 2043
2022
Q1
$288K Sell
62,112
-134,633
-68% -$577K ﹤0.01% 2865
2021
Q4
$984K Buy
196,745
+49,802
+34% +$399K 0.01% 1930
2021
Q3
$1.77M Buy
146,943
+131,858
+874% +$1.92M 0.02% 1108
2021
Q2
$319K Sell
15,085
-26,044
-63% -$627K ﹤0.01% 2285
2021
Q1
$1.15M Buy
41,129
+8,897
+28% +$262K 0.01% 1442
2020
Q4
$838K Buy
32,232
+11,272
+54% +$338K 0.01% 1491
2020
Q3
$779K Buy
20,960
+18,560
+773% +$735K 0.01% 1479
2020
Q2
$123K Sell
2,400
-24,035
-91% -$1.01M ﹤0.01% 2156
2020
Q1
$833K Sell
26,435
-13,389
-34% -$707K 0.02% 949
2019
Q4
$2.38M Buy
39,824
+34,324
+624% +$1.54M 0.04% 651
2019
Q3
$202K Sell
5,500
-19,679
-78% -$780K ﹤0.01% 1768
2019
Q2
$1.17M Buy
25,179
+12,073
+92% +$567K 0.02% 949
2019
Q1
$526K Sell
13,106
-2,428
-16% -$109K 0.02% 1164
2018
Q4
$715K Buy
15,534
+12,150
+359% +$585K 0.03% 736
2018
Q3
$150K Sell
3,384
-772
-19% -$35.4K 0.01% 1497
2018
Q2
$163K Sell
4,156
-6,288
-60% -$318K 0.01% 1418
2018
Q1
$755K Buy
+10,444
New +$767K 0.04% 577
2016
Q1
Sell
-11,854
Closed -$264K 1670
2015
Q4
$264K Buy
11,854
+10,512
+783% +$265K 0.02% 1192
2015
Q3
$32K Buy
1,342
+804
+149% +$50.5K ﹤0.01% 1755
2015
Q2
$44K Sell
538
-7,063
-93% -$691K ﹤0.01% 1716
2015
Q1
$704K Buy
7,601
+1,577
+26% +$102K 0.03% 743
2014
Q4
$244K Buy
+6,024
New +$184K 0.01% 1370

Other funds holding ESPR